Header cover image

Hong Kong (HSI) Drug Retail Industry Analysis

UpdatedAug 12, 2025
DataAggregated Company Financials
Companies6
  • 7D3.7%
  • 3M23.6%
  • 1Y82.6%
  • YTDn/a

The Drug Retail industry is up 5.8% in the last week, with JD Health International up 8.3%. This takes the industry's 12 month performance to a gain of 80%. Looking forward, earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the Hong Kong Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 12 Aug 2025HK$284.7bHK$115.3bHK$4.5b51x63.2x2.5x
Thu, 10 Jul 2025HK$238.4bHK$115.4bHK$4.5b43.7x52.9x2.1x
Sat, 07 Jun 2025HK$222.9bHK$115.3bHK$4.5b46.2x49.5x1.9x
Mon, 05 May 2025HK$232.1bHK$110.0bHK$4.2b64.4x55.9x2.1x
Wed, 02 Apr 2025HK$206.7bHK$110.5bHK$4.2b58.9x49.6x1.9x
Fri, 28 Feb 2025HK$220.7bHK$103.9bHK$3.6b53.1x61.4x2.1x
Sun, 26 Jan 2025HK$165.6bHK$104.4bHK$3.6b38.9x45.8x1.6x
Tue, 24 Dec 2024HK$161.5bHK$103.4bHK$3.6b38.5x45.1x1.6x
Thu, 21 Nov 2024HK$175.5bHK$104.4bHK$3.6b40.2x48.6x1.7x
Sat, 19 Oct 2024HK$171.1bHK$104.8bHK$3.3b49x51.4x1.6x
Mon, 16 Sep 2024HK$133.7bHK$105.4bHK$3.3b35.8x40x1.3x
Wed, 14 Aug 2024HK$133.7bHK$103.0bHK$2.4b39.9x55.4x1.3x
Fri, 12 Jul 2024HK$137.4bHK$101.9bHK$2.4b41.8x57.6x1.3x
Sun, 09 Jun 2024HK$161.7bHK$102.2bHK$2.4b50.1x67.5x1.6x
Tue, 07 May 2024HK$166.5bHK$104.0bHK$2.3b49.4x71.3x1.6x
Thu, 04 Apr 2024HK$151.0bHK$103.9bHK$2.3b45.2x64.8x1.5x
Sat, 02 Mar 2024HK$169.8bHK$105.1b-HK$1,456,456,790.5956.5x-116.6x1.6x
Mon, 29 Jan 2024HK$161.8bHK$105.7b-HK$1,464,110,334.0052.2x-110.5x1.5x
Wed, 27 Dec 2023HK$197.9bHK$105.8b-HK$1,465,895,761.0061.3x-135x1.9x
Fri, 24 Nov 2023HK$221.4bHK$103.9b-HK$1,763,865,808.0088.9x-125.5x2.1x
Sun, 22 Oct 2023HK$200.9bHK$101.8b-HK$1,735,746,037.0083.9x-115.8x2x
Tue, 19 Sep 2023HK$228.2bHK$102.4b-HK$1,676,388,383.0090.7x-136.1x2.2x
Thu, 17 Aug 2023HK$265.5bHK$102.3b-HK$2,681,973,197.0087.2x-99x2.6x
Sat, 15 Jul 2023HK$280.0bHK$96.9b-HK$4,202,451,199.00120.2x-66.6x2.9x
Mon, 12 Jun 2023HK$267.4bHK$96.9b-HK$4,286,907,700.00248.9x-62.4x2.8x
Wed, 10 May 2023HK$294.3bHK$95.2b-HK$4,876,757,306.00442.3x-60.4x3.1x
Fri, 07 Apr 2023HK$319.1bHK$96.0b-HK$4,913,647,545.00481.7x-64.9x3.3x
Price to Earnings Ratio

-201.2x


Total Market Cap: HK$338.0bTotal Earnings: -HK$1,680,431,271.00Total Revenue: HK$91.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Drug Retail Industry Price to Earnings3Y Average 96.1x20242025
Current Industry PE
  • Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 63.4x which is lower than its 3-year average PE of 96.1x.
  • The 3-year average PS ratio of 2.0x is lower than the industry's current PS ratio of 2.5x.
Past Earnings Growth
  • Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 8.2% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Comparison

How does Hong Kong Drug Retail compare with similar industries?

HK Market1.65%
Consumer Staples2.97%
Food and Staples Retail5.27%
Drug Retail3.70%
Food Retail17.93%
Food Distributors4.04%
Big Box Super Stores0.80%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6618 JD Health InternationalHK$52.505.2%
+HK$8.3b
149.4%PE36.9x
1833 Ping An Healthcare and TechnologyHK$12.465.6%
+HK$1.4b
8.7%PE302.7x
241 Alibaba Health Information TechnologyHK$4.950.8%
+HK$644.5m
52.8%PE51x
9886 Dingdang Health Technology GroupHK$0.6210.7%
+HK$79.2m
-42.6%PS0.2x